BIN1 and Alzheimer disease: We first observed a progressive and significant decrease in BIN1 mRNA levels in glutamatergic neurons of both brain regions (Fig. 7A), suggesting that reduced BIN1 expression in this cell type may be a common feature occurring in the AD pathology progression.